CtrlK
Catalyst Pharmaceuticals
CPRX88
$22.52arrow_drop_up1.48%$0.32
NASDAQ - As of Apr 18, 4:36 PM EDT Market Closed
High Quality
High Growth
CPRX88
$22.52
arrow_drop_up1.48%Performance History
arrow_drop_up48.84%
(+$7.39 )
| Key Stats | |
|---|---|
| Open | $22.26 |
| Prev. Close | $22.19 |
| EPS | 1.31 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $2.68B |
| PE Ratio | 17.19 |
| LOW | HIGH | |
|---|---|---|
| Day Range | 22.16 | 22.66 |
| 52 Week Range | 11.89 | 25.65 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
Correlated Companies
About Catalyst Pharmaceuticals (CPRX)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Patrick J. McEnany
- Headquarters
- Coral Gables
- Employees
- 82
- Exchange
- NASDAQ
Keep an eye on Catalyst Pharmaceuticals
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Catalyst Pharmaceuticals 's (CPRX) price per share?
The current price per share for Catalyst Pharmaceuticals (CPRX) is $22.52. The stock has seen a price change of $0.33 recently, indicating a 1.49% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Catalyst Pharmaceuticals (CPRX)?
For Catalyst Pharmaceuticals (CPRX), the 52-week high is $25.66, which is 13.92% from the current price. The 52-week low is $11.89, the current price is 89.4% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Catalyst Pharmaceuticals (CPRX) a growth stock?
Catalyst Pharmaceuticals (CPRX) has shown an average price growth of -1.65% over the past three years. It has received a score of 88 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Catalyst Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Catalyst Pharmaceuticals (CPRX) stock price performance year to date (YTD)?
As of the latest data, Catalyst Pharmaceuticals (CPRX) has a year-to-date price change of 7.91%. Over the past month, the stock has experienced a price change of 3.26%. Over the last three months, the change has been -1.14%. Over the past six months, the figure is 6.43%. Looking at a longer horizon, the five-year price change stands at 391.7%.
help
Is Catalyst Pharmaceuticals (CPRX) a profitable company?
Catalyst Pharmaceuticals (CPRX) has a net income of $163.89M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 86% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 44.31% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $491.73M, with a revenue growth rate of 23.49%, providing insight into the company's sales performance and growth. The gross profit is $422.89M. Operating income is noted at $195.12M. Furthermore, the EBITDA is $226.68M.
help
What is the market capitalization of Catalyst Pharmaceuticals (CPRX)?
Catalyst Pharmaceuticals (CPRX) has a market capitalization of $2.69B. The average daily trading volume is 22.48, indicating the stock's liquidity and investor engagement.